Lighthouse signs business partnership with Bosch

Published: 13-May-2015
Analysis

To supply laser measurement systems for automated pharmaceutical leak detection


Lighthouse Instruments, a US headquartered specialist in laser test and measurement systems for pharmaceutical process monitoring, has entered into a business partnership with Bosch to develop and distribute a new machine series for container closure integrity (CCI) testing using Lighthouse's laser headspace analysis (HSA) technology.

The first machine will be unveiled at Achema in Frankfurt/Main, Germany on 15 June.

Lighthouse will exclusively licence and supply to Bosch laser measurement systems for automated pharmaceutical leak detection. Bosch will be the sole vendor of the machine series while Lighthouse will continue independently to offer measurement services, laboratory instruments and automation for non-leak detection applications to the pharmaceutical industry.

Joachim Baczewski, Head of Inspection Technology and President of Bosch Packaging Technology in Japan, said: 'By combining this expertise and best-in-class technology with our market-leading machinery for pharmaceutical inspection applications, we have developed a highly flexible and customisable leak detection platform.'

The new, fully automated series inspects different containers filled with lyophilised products, as well as medicines filled under vacuum or purged with inert gas.

  • Companies:
  • Bosch
See more

You may also like

Containment

Barrier systems: taking a safety first approach to processing highly potent pharmaceuticals

Read more
To effectively protect humans and products from each other, demand for closed barrier systems such as cRABS and isolators is on the rise

Trending Articles

  1. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  2. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  3. Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success
  4. Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Meeting new USP Chapter 41 requirements Balances are the essential means by which all therapeutics are ultimately supplied in safe dosages. Dirk Ahlbrecht, Sartorius Group, looks at how to ensure measurements are both accurate and up to new USP standards

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Containment

Barrier systems: taking a safety first approach to processing highly potent pharmaceuticals

To effectively protect humans and products from each other, demand for closed barrier systems such as cRABS and isolators is on the rise
Analysis

Bosch Healthcare solutions develops a new all-in-one solution for molecular laboratory diagnostics

Vivalytic is designed to be an open platform compatible with molecular diagnostic tests of various manufacturers, including Randox Laboratories
Manufacturing

Exhibitors quick to sign up for Lab Innovations 2015

Innovation will take centre stage, with numerous exhibitors using the show to launch new products and services to the laboratory market
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

What’s new in inspection technology

New technologies are helping to meet the industry’s increasingly stringent QA requirements. Joachim Baczewski, President of Bosch Packaging Technology in Japan and Head of Inspection Technology, reviews an array of different methods available in the market
Analysis

Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global

The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO
Analysis

Titan Enterprises’ 800-series turbine flow meters provide a low-cost solution for the pharmaceutical industry

Titan's flowmeters can assist in accurate batch delivery and dispensing systems for low viscosity liquids for incorporation in ingestible pharmaceutical products
Regulatory

Isospec Analytics launches biomolecular analysis technology to identify unknown molecules

The novel technology optimises the identification process of unknown molecules compared to mass analysis
Subscribe now